Marker Therapeutics(MRKR) - 2023 Q3 - Quarterly Report

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q DELAWARE 45-4497941 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 9350 Kirby Drive, Suite 300 Houston, Texas 77054 (Address of principal executive offices) (Zip Code) (713) 400-6400 (Issuer's telephone number) 4551 Kennedy Commerce Drive, Houston, Texas, 77032 ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quart ...